Elanco Animal Health (ELAN) Free Cash Flow (2017 - 2026)
Elanco Animal Health (ELAN) reported Free Cash Flow of -$38.0 million for Q1 2026, up 44.93% on a YoY basis from -$26.2 million in Q1 2025, and down 182.61% sequentially from $46.0 million in Q4 2025.
Elanco Animal Health (ELAN) Free Cash Flow (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Free Cash Flow data on file, last reported at -$38.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 44.93% year-over-year to -$38.0 million; the trailing twelve-month figure through Mar 2026 stood at $315.0 million (down 9.22% YoY), and the FY2025 full-year result was $284.0 million, down 27.92% from the prior year.
- Free Cash Flow eased to -$38.0 million in Q1 2026, from $46.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $261.0 million in Q2 2022 to a low of -$169.0 million in Q1 2023.
- A 5-year average of $61.9 million and a median of $116.0 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 1825.0% in 2022 and jumped 773.68% in 2024, its largest moves.
- Tracing ELAN's Free Cash Flow over 5 years: stood at -$64.0 million in 2022, then jumped by 281.25% to $116.0 million in 2023, then increased by 12.07% to $130.0 million in 2024, then sank by 64.62% to $46.0 million in 2025, then slumped by 182.61% to -$38.0 million in 2026.
- Business Quant data shows ELAN's Free Cash Flow at -$38.0 million in Q1 2026, $46.0 million in Q4 2025, and $127.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.00 Mn |
| Mar 31, 2026 | -38.00 Mn |
| Dec 31, 2025 | 46.00 Mn |
| Dec 31, 2025 | 46.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Jun 30, 2025 | 180.00 Mn |
| Jun 30, 2025 | 180.00 Mn |
| Mar 31, 2025 | -69.00 Mn |
| Mar 31, 2025 | -69.00 Mn |
| Dec 31, 2024 | 130.00 Mn |
| Dec 31, 2024 | 130.00 Mn |
| Sep 30, 2024 | 120.00 Mn |
| Sep 30, 2024 | 120.00 Mn |
| Jun 30, 2024 | 166.00 Mn |
| Jun 30, 2024 | 166.00 Mn |
| Mar 31, 2024 | -22.00 Mn |
| Mar 31, 2024 | -22.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Dec 31, 2023 | 116.00 Mn |